Finance & Economics

Intellia Therapeutics Delivers a Q4 Beat

Intellia Therapeutics reported better-than-expected results for the fourth quart...

Goldman Sachs downgraded partly on ‘disappointing’ star...

Expectations of a banner year in dealmaking have not yet materialized due to wor...

Eli Lilly wants to make drugs in America. First it want...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announc...

Ben & Jerry’s founders discuss buying back ice cream brand

The two sides have been fighting since 2021, when Ben & Jerry’s said it would ha...

Nvidia Beat Earnings, but the Stock Is Down. What's Goi...

In this video, I will go over Nvidia's (NASDAQ: NVDA) earnings report and commen...

Goldman Sachs erases diversity goals and scrubs pages a...

"We strongly believe that merit and diversity are not mutually exclusive," CEO D...

Democrat proposes MEME Act to stop Trump and other top ...

The new bill follows presidential forays into memecoins from Donald Trump, the p...

Eli Lilly plans to make drugs in America. First, it wan...

Eli Lilly (LLY), the maker of the blockbuster weight-loss drug Zepbound, announc...

America's economy is flashing warning signs of a slowdown

The U.S. economy is beginning to show signs of a slowdown — and the situation is...

This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.